The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients
Cardiovascular complications arising from COVID-19 are known to contribute significantly to mortality rates. In fact, although the lungs are the main organs involved in COVID-19, one of the major systems affected by the virus is the cardiovascular system. Early detection of cardiovascular complications would enable health professionals to provide tailored treatment and ultimately reduce the burden of disease, which is precisely what the COVIRNA project is trying to address.
The COVIRNA project is a patient-centred Innovation Action focused on developing an innovative diagnostic test that can improve individualised surveillance, care and follow-up of COVID-19 patients by identifying those who are at risk of developing fatal cardiovascular complications.
This session will first examine the impact and benefits of the adoption of novel diagnostic tools in times of pandemic. In particular, it will look at how health managers can help design patient-centred care pathways and create enabling environments for the uptake of innovative tools such as COVIRNA. The session will then discuss how patient-centred care and personalised medicine can improve health outcomes and enhance patients’ quality of life. In fact, personalised disease management and personalised medicine move away from a one-size-fits-all solution in favour of an approach that recognises the genomic and clinical specificities of each individual patient, and the different forms complex diseases can take. Treatments and care planning can therefore be tailored and adapted to patients to ultimately improve their health outcomes by making treatments more effective and with fewer side effects. Lastly, the session will dive into how we can bring innovations to patients, and how COVIRNA could be used in future pandemics.
Join the session on Friday, 17 June at 11:15 AM CET at the EHMA 2022 Annual Conference to discuss how we can design more patient-centric care pathways together with the following esteemed speakers:
- Dr Yvan Devaux, Head of the Cardiovascular Research Unit at Luxembourg Institute of Health;
- Dr Damien Gruson, Chief of Department of Laboratory Medicine of the St-Luc Hospital;
- Ed Harding, Director of the Heart Failure Policy Network and Managing Director of The Health Policy Partnership; and
- Prof Sandra Buttigieg, Head of Department Health Systems Management and Leadership at the University of Malta.
To learn more about the COVIRNA project, its goals and objectives, you can visit the project’s website.